File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1093/ndt/gfh891
- Scopus: eid_2-s2.0-26444541329
- PMID: 15899935
- WOS: WOS:000231055400024
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients
Title | Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients |
---|---|
Authors | |
Keywords | Atherosclerosis Calcification Fetuin-A Inflammation Malnutrition Peritoneal dialysis |
Issue Date | 2005 |
Publisher | Oxford University Press. The Journal's web site is located at http://ndt.oxfordjournals.org/ |
Citation | Nephrology Dialysis Transplantation, 2005, v. 20 n. 8, p. 1676-1685 How to Cite? |
Abstract | Background. Fetuin-A (α 2-Heremans Schmid glycoprotein) has recently been identified as a circulating inhibitor of calcification and is regulated as a negative acute phase protein. However, its relationships with cardiac valvular calcification and atherosclerosis and outcome have not been evaluated in peritoneal dialysis (PD) patients. Method. We performed a prospective follow-up study in 238 PD patients with echocardiography done at baseline to detect cardiac valvular calcification and biochemical analysis performed for serum fetuin-A, albumin and C-reactive protein (CRP). Results. Baseline serum fetuin-A concentration was (mean±SD) 0.309±0.068 g/l (normal range 0.4-0.95). Across the three tertiles of increasing serum fetuin-A, a significant trend effect was observed for age (P = 0.023), diabetes (P = 0.008), background atherosclerotic vascular disease (P = 0.010), cardiac valvular calcification (P = 0.002), serum albumin (P<0.001), subjective global assessment (P = 0.005) and CRP (P<0.001). Adjusti0ng for CRP and calcium × phosphorus product, every 0.01 g/l increase in serum fetuin-A remained independently associated with a 6% decrease in the risk of valvular calcification (95% confidence intervals, 0.90-0.99; P = 0.028). Furthermore, serum fetuin-A showed a significant decrease across the four groups of patients with increasing components of the malnutrition, inflammation, atherosclerosis/calcification (MIAC) syndrome (P<0.001) and was the lowest among patients with all components of the MIAC syndrome (0.263±0.055 g/l) and highest among those who do not have the MIAC syndrome at all (0.338±0.06 g/l). Lower serum fetuin-A was associated with greater all-cause mortality (P = 0.0011) and fatal and non-fatal cardiovascular events (P = 0.0017), but its significance was lost when atherosclerotic vascular disease, valvular calcification, inflammation and malnutrition were included in the model. Conclusions. Serum fetuin-A showed important associations with valvular calcification, atherosclerosis, malnutrition and inflammation, and was linked to mortality and cardiovascular events in PD patients via its close relationships with the MIAC syndrome. © The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/162888 |
ISSN | 2023 Impact Factor: 4.8 2023 SCImago Journal Rankings: 1.414 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, AYM | en_US |
dc.contributor.author | Woo, J | en_US |
dc.contributor.author | Lam, CWK | en_US |
dc.contributor.author | Wang, M | en_US |
dc.contributor.author | Chan, IHS | en_US |
dc.contributor.author | Gao, P | en_US |
dc.contributor.author | Lui, SF | en_US |
dc.contributor.author | Li, PKT | en_US |
dc.contributor.author | Sanderson, JE | en_US |
dc.date.accessioned | 2012-09-05T05:24:50Z | - |
dc.date.available | 2012-09-05T05:24:50Z | - |
dc.date.issued | 2005 | en_US |
dc.identifier.citation | Nephrology Dialysis Transplantation, 2005, v. 20 n. 8, p. 1676-1685 | en_US |
dc.identifier.issn | 0931-0509 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/162888 | - |
dc.description.abstract | Background. Fetuin-A (α 2-Heremans Schmid glycoprotein) has recently been identified as a circulating inhibitor of calcification and is regulated as a negative acute phase protein. However, its relationships with cardiac valvular calcification and atherosclerosis and outcome have not been evaluated in peritoneal dialysis (PD) patients. Method. We performed a prospective follow-up study in 238 PD patients with echocardiography done at baseline to detect cardiac valvular calcification and biochemical analysis performed for serum fetuin-A, albumin and C-reactive protein (CRP). Results. Baseline serum fetuin-A concentration was (mean±SD) 0.309±0.068 g/l (normal range 0.4-0.95). Across the three tertiles of increasing serum fetuin-A, a significant trend effect was observed for age (P = 0.023), diabetes (P = 0.008), background atherosclerotic vascular disease (P = 0.010), cardiac valvular calcification (P = 0.002), serum albumin (P<0.001), subjective global assessment (P = 0.005) and CRP (P<0.001). Adjusti0ng for CRP and calcium × phosphorus product, every 0.01 g/l increase in serum fetuin-A remained independently associated with a 6% decrease in the risk of valvular calcification (95% confidence intervals, 0.90-0.99; P = 0.028). Furthermore, serum fetuin-A showed a significant decrease across the four groups of patients with increasing components of the malnutrition, inflammation, atherosclerosis/calcification (MIAC) syndrome (P<0.001) and was the lowest among patients with all components of the MIAC syndrome (0.263±0.055 g/l) and highest among those who do not have the MIAC syndrome at all (0.338±0.06 g/l). Lower serum fetuin-A was associated with greater all-cause mortality (P = 0.0011) and fatal and non-fatal cardiovascular events (P = 0.0017), but its significance was lost when atherosclerotic vascular disease, valvular calcification, inflammation and malnutrition were included in the model. Conclusions. Serum fetuin-A showed important associations with valvular calcification, atherosclerosis, malnutrition and inflammation, and was linked to mortality and cardiovascular events in PD patients via its close relationships with the MIAC syndrome. © The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. | en_US |
dc.language | eng | en_US |
dc.publisher | Oxford University Press. The Journal's web site is located at http://ndt.oxfordjournals.org/ | en_US |
dc.relation.ispartof | Nephrology Dialysis Transplantation | en_US |
dc.subject | Atherosclerosis | - |
dc.subject | Calcification | - |
dc.subject | Fetuin-A | - |
dc.subject | Inflammation | - |
dc.subject | Malnutrition | - |
dc.subject | Peritoneal dialysis | - |
dc.subject.mesh | Arteriosclerosis - Blood - Etiology | en_US |
dc.subject.mesh | Blood Proteins - Metabolism | en_US |
dc.subject.mesh | C-Reactive Protein - Metabolism | en_US |
dc.subject.mesh | Calcinosis - Blood - Etiology | en_US |
dc.subject.mesh | Echocardiography | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Heart Valve Diseases - Blood - Etiology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Inflammation - Blood - Etiology | en_US |
dc.subject.mesh | Kidney Failure, Chronic - Therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Malnutrition - Blood | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Peritoneal Dialysis | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Serum Albumin - Metabolism | en_US |
dc.subject.mesh | Survival Rate | en_US |
dc.subject.mesh | Syndrome | en_US |
dc.subject.mesh | Alpha-2-Hs-Glycoprotein | en_US |
dc.title | Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients | en_US |
dc.type | Article | en_US |
dc.identifier.email | Wang, M:meiwang@hkucc.hku.hk | en_US |
dc.identifier.authority | Wang, M=rp00281 | en_US |
dc.description.nature | link_to_OA_fulltext | en_US |
dc.identifier.doi | 10.1093/ndt/gfh891 | en_US |
dc.identifier.pmid | 15899935 | - |
dc.identifier.scopus | eid_2-s2.0-26444541329 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-26444541329&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 20 | en_US |
dc.identifier.issue | 8 | en_US |
dc.identifier.spage | 1676 | en_US |
dc.identifier.epage | 1685 | en_US |
dc.identifier.isi | WOS:000231055400024 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Wang, AYM=13606226000 | en_US |
dc.identifier.scopusauthorid | Woo, J=36040369400 | en_US |
dc.identifier.scopusauthorid | Lam, CWK=8531362100 | en_US |
dc.identifier.scopusauthorid | Wang, M=7406690398 | en_US |
dc.identifier.scopusauthorid | Chan, IHS=8298775100 | en_US |
dc.identifier.scopusauthorid | Gao, P=55065678700 | en_US |
dc.identifier.scopusauthorid | Lui, SF=7102379144 | en_US |
dc.identifier.scopusauthorid | Li, PKT=25928016800 | en_US |
dc.identifier.scopusauthorid | Sanderson, JE=7202371250 | en_US |
dc.identifier.citeulike | 264676 | - |
dc.identifier.issnl | 0931-0509 | - |